Inflammation News and Research

RSS

COVID-19 works with the body's microbiota to increase disease severity in obese and diabetic patients

The combined effects of the body's microbiota working together with COVID-19 in the lungs could explain the severity of the disease in people with obesity and diabetes, according to a new article published today in eLife.

15 Sep 2020

Study reveals damaging role of immune system in severe brain infection

A new study has detailed the damaging role played by the immune system in a severe brain condition most commonly caused by the cold sore virus.

15 Sep 2020

Study explores how sleep affects people's reaction to both stressful and positive events

New research from UBC finds that after a night of shorter sleep, people react more emotionally to stressful events the next day--and they don't find as much joy in the good things.

15 Sep 2020

New biomarker can reliably predict aggressiveness of biliary tract cancer

The cancer called biliary tract cancer (BTC) is not the most widespread form of cancer. In western countries, about 1.6 in 100.000 gets the diagnose every year. It is, however, a very aggressive form of cancer.

15 Sep 2020

Study uncovers a promising new therapeutic approach for Duchenne muscular dystrophy

Scientists at Sanford Burnham Prebys Medical Discovery Institute, Fondazione Santa Lucia IRCCS, and Università Cattolica del Sacro Cuore in Rome have shown that pharmacological (drug) correction of the content of extracellular vesicles released within dystrophic muscles can restore their ability to regenerate muscle and prevent muscle scarring (fibrosis).

15 Sep 2020

WSU researchers use soy to improve post-operative treatment of bone cancer

Researchers in recent years have demonstrated the health benefits of soy, linking its consumption to reduced risk of cardiovascular disease, obesity, cancer and improved bone health.

15 Sep 2020

Patients on immunosuppressive therapy are not at increased risk for contracting COVID-19

Patients on immunosuppressive therapy for common skin and rheumatic diseases like psoriasis and rheumatoid arthritis are not at increased risk for contracting COVID-19 and should continue taking their medicine as prescribed, say Henry Ford Health System dermatology researchers in a study published in the Journal of the American Academy of Dermatology.

15 Sep 2020

Biologic therapy for psoriasis could lead to significant reduction in heart disease

Patients with psoriasis treated with biologic therapy, which are protein-based infusions to suppress inflammation, had a significant reduction in high-risk plaque in heart arteries, over one-year, according to new research published today in Circulation: Cardiovascular Imaging, an American Heart Association journal.

15 Sep 2020

COVID-19 ‘long-haulers’ experience lingering health effects

Called “long-haulers” or “long-termers,” some people report lingering symptoms of the illness for months. These people experience symptoms ranging from fatigue and weakness to chest pains and difficulty breathing.

15 Sep 2020

NIH and FDA examine serious side effect that surfaced in COVID vaccine trial

The Food and Drug Administration is weighing whether to follow British regulators in resuming a coronavirus vaccine trial that was halted when a participant suffered spinal cord damage, even as the National Institutes of Health has launched an investigation of the case.

14 Sep 2020

RUDN geneticist finds a bifidobacterial protein that can reduce inflammation in COVID-19

A geneticist from RUDN University studied the effect of Bifidobacterium (intestinal bacteria) on the inflammatory process and discovered that their surface protein is capable of stopping excessive or uncontrollable inflammation, like the one observed in COVID-19 patients.

14 Sep 2020

NIH awards $26.56 million grant to create new Framingham Heart Study Brain Aging Program

Since 1976, the Framingham Heart Study (FHS)--the longest running multi-generational epidemiological study in the world--has followed participants for incident dementia.

14 Sep 2020

Researchers receive $2.5 million grant to develop and analyze breast tumor organoids

Breast cancer is the second most common cancer diagnosed in women in the United States after skin cancer, and women with comorbidities (the presence of more than one condition/disease) often fare worse in terms of their breast cancer.

14 Sep 2020

Smoke from wildfires may increase COVID-19 risk

The smoke the firefighters are breathing is heightening their risk of contracting the new coronavirus, with potentially life-threatening effects. Further, fighting the huge fires may make infection control measures such as hand washing and social distancing, challenging to perform.

14 Sep 2020

Earlier treatment with steroids reduces adverse outcomes in patients with septic shock

Some critically ill patients with septic shock need medications called vasopressors to correct dangerously low blood pressure.

14 Sep 2020

Keto diet could be beneficial for elderly COVID-19 patients

A recent study by researchers at Yale School of Medicine, New York University Langone Health and Washington University School of Medicine, claims that the ketogenic diet (high fat, low carbohydrate diet) is capable of mitigating clinical outcomes of coronavirus disease 2019 (COVID-19) in elderly people by improving immune-metabolic functions and reducing inflammation. The study is currently available on the bioRxiv* preprint server.

14 Sep 2020

Inflammation News and Research

COVID-19 works with the body's microbiota to increase disease severity in obese and diabetic patients

Study reveals damaging role of immune system in severe brain infection

Study explores how sleep affects people's reaction to both stressful and positive events

New biomarker can reliably predict aggressiveness of biliary tract cancer

Study uncovers a promising new therapeutic approach for Duchenne muscular dystrophy

WSU researchers use soy to improve post-operative treatment of bone cancer

Patients on immunosuppressive therapy are not at increased risk for contracting COVID-19

Biologic therapy for psoriasis could lead to significant reduction in heart disease

COVID-19 ‘long-haulers’ experience lingering health effects

NIH and FDA examine serious side effect that surfaced in COVID vaccine trial

RUDN geneticist finds a bifidobacterial protein that can reduce inflammation in COVID-19

NIH awards $26.56 million grant to create new Framingham Heart Study Brain Aging Program

Researchers receive $2.5 million grant to develop and analyze breast tumor organoids

Smoke from wildfires may increase COVID-19 risk

Earlier treatment with steroids reduces adverse outcomes in patients with septic shock

Keto diet could be beneficial for elderly COVID-19 patients

Sticky DNA webs may cause tissue damage associated with severe COVID-19 infections

Researchers develop new PET imaging agent that spotlights inflammation

Cell signaling research rings warning bells over an emerging cancer drug target

Sleep apnea patients could be at increased risk of adverse outcomes from COVID-19

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News